(Q24200368)

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Clinical and neurochemical effects of fenfluramine in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Fluoxetine in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

A pilot study of clomipramine in young autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Medication patterns in patients with autism: temporal, regional, and demographic influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Selective serotonin re-uptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Global prevalence of autism and other pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

The Yale-Brown Obsessive Compulsive Scale. II. Validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Adult outcome for children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Risperidone for autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

An update on pharmacologic treatments for autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Risperidone in children with autism and serious behavioral problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

The Children's Yale-Brown Obsessive-Compulsive Scale: item structure in an outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Do selective serotonin reuptake inhibitors cause suicide? Antidepressant prescribing to children and adolescents by GPs has fallen since CSM advice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Medication Use Among Children with Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Serotonin receptors: subtypes, functional responses and therapeutic relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Auditory integration training and other sound therapies for autism spectrum disorders (ASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Systematic review of prevalence studies of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3

The serotonin system in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004677.PUB3